Fans are encouraged to vote as often as allowed at MarionStar.com and its app for their favorite athletes in our latest polls through Sunday morning.

Maine's Androscoggin River has earned a spot on a list featuring some of the most prestigious fly fishing rivers in the U.S., ...

Maine's Androscoggin River has earned a spot on a list featuring some of the most prestigious fly fishing rivers in the U.S., ...

Boys basketball: Pleasant snaps River Valley's string of blowout victories Saturday in boys basketball Girls ... to win it. Other nominees were Mount Gilead wrestler Cody Meimer, RV swimmer Braden ...

GS-0272 is under clinical development by Gilead Sciences and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase I drugs for Rheumatoid Arthritis have a 69% phase transition ...

Gilead Sciences Inc. and the federal government settled a patent-infringement case in which the US sought $1 billion from the bioscience giant for allegedly using joint research to develop an ...

After a run of court victories in a five-year patent dispute with the U.S. government, Gilead Sciences has agreed to settle with the Department of Justice (DOJ) and the Department of Health and ...

Brian Heath has joined Gilead Sciences’ cell therapy subsidiary as a senior vice president and head of global commercial, he announced on LinkedIn this week. “CAR T-cell therapy has changed ...

(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware ...

AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for sustainable success in 2025. With explosive deals out of the way, news from ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. The litigation ...